<DOC>
	<DOCNO>NCT01241240</DOCNO>
	<brief_summary>This study evaluate safety efficacy Triple Combination Therapy compare Fixed Combination brimonidine tartrate/timolol ophthalmic solution patient primary open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Safety Efficacy Triple Combination Therapy Patients With Primary Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Ocular hypertension primary openangle glaucoma eye Requires treatment IOPlowering medication eye Required chronic use ocular medication study study medication Use corticosteroid within 30 day History prior eye surgery , except uncomplicated eye surgery perform 6 month Screening visit Anticipated wear contact lens study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>